![Thermo Fisher: Slowing Growth Suggests Acquisition-Heavy Company Is Overvalued (NYSE:TMO) | Seeking Alpha Thermo Fisher: Slowing Growth Suggests Acquisition-Heavy Company Is Overvalued (NYSE:TMO) | Seeking Alpha](https://static.seekingalpha.com/uploads/2020/2/7/49171940-15810878358257642_origin.png)
Thermo Fisher: Slowing Growth Suggests Acquisition-Heavy Company Is Overvalued (NYSE:TMO) | Seeking Alpha
![CROs Remain Hot Commodity as Thermo Fisher Announces Plans for $17.4B Acquisition of PPD | Inside Precision Medicine CROs Remain Hot Commodity as Thermo Fisher Announces Plans for $17.4B Acquisition of PPD | Inside Precision Medicine](https://www.insideprecisionmedicine.com/wp-content/uploads/2020/02/0120-CO-CancerDx-GenexusTech-696x464.jpg)
CROs Remain Hot Commodity as Thermo Fisher Announces Plans for $17.4B Acquisition of PPD | Inside Precision Medicine
![Thermo Fisher Scientific Inc. - Thermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization Thermo Fisher Scientific Inc. - Thermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization](https://mma.prnewswire.com/media/1488649/PPD_Logo.jpg)
Thermo Fisher Scientific Inc. - Thermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization
![Thermo Fisher revenue climbs 22% for 2021, buoyed by product launches and the year's biggest buyout | Fierce Biotech Thermo Fisher revenue climbs 22% for 2021, buoyed by product launches and the year's biggest buyout | Fierce Biotech](https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1643820235/Thermo%20Fisher%20HQ%20.jpg/Thermo%20Fisher%20HQ%20.jpg?VersionId=8Q1OySNA8jBWe2vVjNH5MRnoq20_Znca)